Sort   by:  
 Page size 
UnknownDeveloping an AI-Assisted Tool That Identifies Patients With Multimorbidity and Complex Polypharmacy to Improve the Process of Medication Reviews: Qualitative Interview and Focus Group Study.
Not available
S-EPMC12828319 | biostudies-literature
UnknownA qualitative exploration of barriers to efficient and effective structured medication reviews in primary care: Findings from the DynAIRx study.
Not available
S-EPMC11364411 | biostudies-literature
UnknownThe Toxicity of Microplastics Explorer (ToMEx) 2.0.
Not available
S-EPMC12474654 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownECMO for COVID-19 patients in Europe and Israel.
Not available
S-EPMC7796689 | biostudies-literature
UnknownIn-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study.
Not available
S-EPMC9671669 | biostudies-literature
UnknownHospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.
Not available
S-EPMC8397301 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownDimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10831058 | biostudies-literature
UnknownSARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2.
Not available
S-EPMC9326417 | biostudies-literature
Sort   by:  
 Page size